Exhibit 16.1
October 29, 2018
U.S. Securities and Exchange Commission
100 F. Street
Washington, DC 20549-7561
Ladies and Gentleman:
RE: Heyu Biological Technology Corporation
Commission File No. 000-26731
Heyu Biological Technology Corporation pertaining to our firm included in Item 4.01 of the Form 8-K dated October 29, 2018, and are in agreement with the statements contained in that document pertaining to our firm.
Sincerely, | ||
/s/ Haynie & Company | ||
Haynie & Company |